SMS Reminder for Forgotten Ureteral Stents

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-05-31

Study Completion Date

2011-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ureteral stents has become an indispensable instrument for urology practice as a result of widespread use of endourological interventions. Removal of stents could be sometimes neglected by patients or physicians. This omission may lead to legal and medical problems for urologists, health institutions and also for patients. In this study, the investigators offer a computer program providing two sided recall to prevent this nasty complication with sending automatic message by short message service (SMS) to both the patient and the urologist.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, first an institutional subscription agreement was signed between our university and a mobile phone cell company which is supporting SMS sending program. In the second step, by making software plug-in to our hospital's patient follow up program, two programs were integrated. According to this integration, after stent insertion, in case of entering the numerical code corresponding of ''ureteral stent application'' procedure during the stage of epicrisis preparation, the patient follow up system warns the official recording the epicrisis to enter the stent removal time. Patient follow up system transfers this information to SMS sending program. After several weeks of the procedure, if the stent needs to be removed, the software automatically sends a warning message to the patient and the physician. If the patients attends to urology department and undergoes stent removal, the official enters the code of "endoscopic stent removal" to the patient follow-up program. Then the program stops to send warning message.

By the software plug-in to patient follow up program, SMS sending was made mandatory not to forget or skip none of the patients during the epicrisis writing procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stents

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

forgotten ureteral stents, SMS Reminder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Forgotten ureteral stents

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who had ureteral stent insertion.

Exclusion Criteria

* Patients who did not want SMS message from us or want to give cell phone number.

Minimum Eligible Age

1 Year

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

School of Medicine

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ahmet A Sancaktutar, Asist Prof.

Role: PRINCIPAL_INVESTIGATOR

Department of Urology, Dicle University School of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dicle University School of Medicine

Diyarbakır, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1-Dicle University

Identifier Type: -

Identifier Source: org_study_id